A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Condition: Chronic Thromboembolic Pulmonary Hypertension Interventions: Drug: Macitentan; Drug: Placebo Sponsor: Actelion Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials